VB
VBI Vaccines
VBIV·NASDAQCambridge MAFounded 2007100 employees
Micro CapbiotechPublicInfectious Disease
Platform: VBI-2901 eVLP
Market Cap
$0.02B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (VBIV)
Loading VBIV stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| VBI-124 | VBI-124 | Phase 2/3 | 2 | FGFR | Melanoma | ||
| Doxazumab | VBI-5892 | Phase 1/2 | 2 | FGFR | MSLGS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)